Press Releases

All Releases
View Summary Five Prime Therapeutics to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Thursday, January 8, 2015
PDF 6.3 KB Add to Briefcase
View Summary Five Prime Therapeutics Prices Public Offering of Common Stock
Tuesday, January 6, 2015
PDF 6.3 KB Add to Briefcase
View Summary Five Prime Announces $75 Million Proposed Public Offering of Common Stock
Monday, January 5, 2015
PDF 8.1 KB Add to Briefcase
View Summary Five Prime Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference
Thursday, December 4, 2014
PDF 13.2 KB Add to Briefcase
View Summary Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Clinical Trial Evaluating FPA144 in Gastric Cancer
Thursday, December 4, 2014
PDF 8.7 KB Add to Briefcase
View Summary Five Prime Therapeutics to Present at The 26th Annual Piper Jaffray Healthcare Conference
Tuesday, November 25, 2014
PDF 13.5 KB Add to Briefcase
View Summary Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types
Monday, November 24, 2014
PDF 17.1 KB Add to Briefcase
View Summary Five Prime Therapeutics Initiates Dosing of Rheumatoid Arthritis Patients in Its Phase 1 Clinical Trial of FPA008
Monday, November 17, 2014
PDF 16.1 KB Add to Briefcase
View Summary Five Prime Therapeutics to Present Data From Healthy Volunteer Cohorts in Phase 1 Trial of FPA008 at the 2014 ACR/ARHP Annual Scientific Meeting
Thursday, November 13, 2014
PDF 11.8 KB Add to Briefcase
View Summary Five Prime Therapeutics Announces Third Quarter 2014 Financial Results
Monday, November 10, 2014
PDF 17.1 KB Add to Briefcase
View Summary Five Prime Therapeutics Announces Presentation at the 2014 Society for Immunotherapy of Cancer Annual Meeting
Wednesday, November 5, 2014
PDF 8.7 KB Add to Briefcase
View Summary Five Prime Therapeutics to Announce Third Quarter 2014 Financial Results and Host Conference Call on November 10
Monday, November 3, 2014
PDF 6.4 KB Add to Briefcase
View Summary Five Prime Therapeutics Announces Expansion of Respiratory Disease Research Collaboration and License Agreement With GSK
Thursday, October 23, 2014
PDF 7.3 KB Add to Briefcase
View Summary Five Prime Therapeutics Appoints Bill Ringo to Its Board of Directors
Thursday, October 2, 2014
PDF 6.8 KB Add to Briefcase
View Summary Five Prime Therapeutics Appoints Dr. Robert Sikorski as Vice President of Global Clinical Development
Wednesday, September 17, 2014
PDF 6.8 KB Add to Briefcase
View Summary Five Prime Therapeutics Announces Option Exercise by GlaxoSmithKline for a Commercial License to a Novel Muscle Disease Target
Monday, September 15, 2014
PDF 17.1 KB Add to Briefcase
View Summary Five Prime Therapeutics to Present at Morgan Stanley 2014 Global Healthcare Conference
Wednesday, September 3, 2014
PDF 6.6 KB Add to Briefcase
View Summary Five Prime Therapeutics Announces Second Quarter 2014 Financial Results
Tuesday, August 5, 2014
PDF 15.4 KB Add to Briefcase
View Summary Five Prime Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 5, 2014
Tuesday, July 29, 2014
PDF 6.3 KB Add to Briefcase
View Summary Five Prime Therapeutics to Present at 2014 Wells Fargo Healthcare Conference
Wednesday, June 11, 2014
PDF 6.4 KB Add to Briefcase
Showing 81-100 of 159 Page: 1 2 3 4 5 6 7 8  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

FPRX (Common Stock)

Exchange
NASDAQ
Price
47.26
Change (%)
+0.79
Volume
257,817

Data as of 12:12 PM ET on Friday, February 24, 2017
Minimum 20 minute delay
Refresh quote
Powered By eSignal, Inc.